CN Stock MarketDetailed Quotes

002332 Zhejiang Xianju Pharmaceutical

Watchlist
  • 9.79
  • -0.05-0.51%
Market Closed Jan 23 15:00 CST
9.68BMarket Cap15.59P/E (TTM)

Zhejiang Xianju Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zhejiang Xianju Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 5.263B--
--2024/FY-- / 4.563B--
--2023/FY4.123B / 4.307B--
--2022/FY4.380B / 4.594B--
--2021/FY4.345B / 4.629B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 5.263B--
--2024/FY-- / 4.563B--
--2023/FY4.123B / 4.307B--
--2022/FY4.380B / 4.594B--
--2021/FY4.345B / 4.629B--

Unlock Free Earnings Estimates

Zhejiang Xianju Pharmaceutical Earnings Reports

  • Xianju Pharmaceutical: Report for the third quarter of 2024

    Oct 25, 2024 12:00 ET

  • Xianju Pharmaceutical: 2024 Semi-Annual Report Summary

    Aug 26, 2024 12:00 ET

  • Xianju Pharmaceutical: Semi-Annual Report 2024

    Aug 26, 2024 12:00 ET

  • Xianju Pharmaceutical: Report for the first quarter of 2024

    Apr 24, 2024 12:00 ET

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    Fuling Technology
    001356
    23.28 +339.25%
    KLT
    831689
    27.66 +25.05%
    Hand Enterprise Solutions
    300170
    16.30 +17.69%
    GRANDTECH
    835184
    13.14 +16.49%
    Doushen(Beijing) Education & Technology Inc.
    300010
    7.25 +16.00%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Jan 23, 2025

    Strong Buy

    • Strong Buy

      88.24%

    • Buy

      11.77%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme State-owned Enterprise Reform
    State-owned Enterprise Reform
    Intraday+0.70%
    Transferring Securities of Securities
    Transferring Securities of Securities
    Intraday+0.48%
    Finance and Securities Lending
    Finance and Securities Lending
    Intraday+0.48%